We have investigated if cultivated muscle cells from malignant hyperthermia (MH) patients can be distinguished pharmacologically from controls. Muscle specimens from four individuals carrying the Gly2435Arg mutation of the skeletal muscle ryanodine receptor protein (RYRI) and from four controls were used to culture myotubes. Resting intracellular calcium concentration ([Ca 2+ ]j) of MH myotubes was similar to controls. However, when ryanodine 0.5 umol litre" 1 was added, the kinetics of the increase in the calcium signals in MH and control cells were significantly different; the time for half maximum increase was mean 197 (SD 131) s for MH cells and 474 (61) s for controls (n=80 cells each). On average, the area under the MH response curves was twice the control value. These results give rise to hopes that the phenotype of MH can be characterized using cultured human muscle and that a culture-based test for MH susceptibility may eventually be developed.
"
3 It is believed to be caused by disturbed the near future. myoplasmic calcium homeostasis. More than half of the At present, the only accepted test for MH is based on individuals susceptible to MH are likely to carry mutations pharmacological criteria. The in vitro contracture test in the gene encoding the skeletal muscle ryanodine (IVCT) 14 15 requires bundles of muscle fibres obtained at receptor (RYRI). 4 The symptoms of muscle rigidity, open biopsy to be exposed to caffeine and halothane. hyperthermia and increased energy turnover are second-Ryanodine 16 17 and/or 4-chloro-m-cresol 18 19 can also ary effects. 5 be used as trigger substances. Muscle with increased To date, 19 point mutations in the RYRI gene have sensitivity to both halothane and caffeine is classified as been associated with MH. 6 7 All mutations predict amino MH susceptible (MHS). The IVCT has a high sensitivity acid changes in the huge cytoplasmic domain of RYRI. and specificity but the procedure is invasive, complicated Two of these (Arg614Cys and Gly2435Arg) bestow on and has to be performed within a few hours of biopsy, the channel increased sensitivity to calcium, increased A test based on cultured muscle would be less harmful ryanodine binding affinity and less inhibitory effect of and would allow study of the pathophysiology of the calmodulin. Thus the mutations render the release channel various MH phenotypes in detail, as cultures can be overactive. 8 Similar observations were made in pig muscle expanded, frozen and thawed. carrying a homologous mutation predicting Arg615Cys. 9 Cultured muscle expresses the RYRI gene, and porcine Genetic linkage studies indicate the existence of at least myotubes carrying the Arg615Cys mutation showed a four other MH loci on chromosomes 3q, 10 7q, n lq 12 and lower threshold for contraction when stimulated with longBritish Journal of Anaesthesia In this study, we have investigated more thoroughly calcium homeostasis in myotubes from MH patients with a distinct RYR1 mutation with special regard to the possibility of determining MH susceptibility using cultured muscle.
Patients and methods

Patients
The m. vastus lateralis was biopsied in a patient who had undergone an MH crisis and in three of his relatives who wanted to be tested for MH susceptibility. Their ages were 16-63 yr. MH tests were performed according to the European protocol for the in vitro contracture test.
14 In addition to their responses to caffeine and halothane, the muscle bundles were also tested for their sensitivity to ryanodine. 16 All tests gave positive results (Table 1) . PCR analysis revealed that the four MHS individuals were heterozygous for the Gly2435Arg mutation of the RYR1 gene. 8 For controls, we used muscle samples from three individuals who were classified as MH negative (MHN) according to the European IVCT protocol. A fourth control muscle sample was obtained from a patient with no muscle disease who had undergone orthopaedic surgery. The muscle specimens were transported to the laboratory in Krebs solution (Life Technologies, Eggenstein, Germany). A section of the sample from each patient was put aside for preparation of mononucleated cells. The study was conducted in accordance with the Helsinki convention and approved by the Ethics Commission of the University of Ulm. All donors gave informed consent to the experiments.
Muscle cultures
Muscle samples of 300-600 mg in weight were used for the enzymatic isolation of mononucleated cells or stored in Hank's solution (Biochrom, Berlin, Germany) for several hours at 4°C. Primary cultures were grown as described previously. 23 They were frozen before myotube formation began and stored for up to 1 yr at -196°C. On thawing, the first myotubes began to form after 6-8 days of culture. Recordings of [Ca 2+ ]; were performed between 5 and 10 days after the first myotube formation. The cultures had reached about 50% confluence at that time and the multinucleated myotubes could be distinguished easily form mononucleated fibroblast-like cells. To exclude artefacts, cultures were thawed and grown in pairs of MHS and control, and all recordings from these cultures at a corresponding stage were made on the same day in parallel.
Recordings of free cytosolic Ca
2+
[Ca 2+ ]; was determined using the calcium-sensitive dye fura-2. To load the cells with the dye, the cultures growing in a dish of 6 cm diameter were washed three times with Hank's solution and then incubated for 45 min at 37°C in Hank's solution containing fura2/AM* 1.2 nmol litre" 1 . After loading, the cells were washed three times with standard external solution, and then 18 ml of external solution was added. The whole culture was heated to the desired temperature of 37°C and then kept for no longer than 1 h before experimentation.
An inverted microscope and equipment for UV excitation (alternating between 340 nm and 380 nm) and fast photometric detection (MPM 200, Zeiss, Oberkochen, Germany) was used to determine the ratio R of the fluorescent signals in cells or parts of single myotubes. A cell-free calibration of the recording system was performed using 15 different strongly Ca-buffered solutions of (mmol litre" 1 ) KC1 100; HEPES 10; EGTA/KOH 5; HEDTA/KOH 5; NTA/KOH 5; and fura-2 0.01 (pH 7.4). Appropriate amounts of Mg 2+ and Ca 2+ were added to this stock to obtain standards with a final free Mg fitted to the data to determine Rmin (the ratio of fluorescence emission intensities at 340 and 380 nm excitation under Ca 2+ -free conditions), Rmax (this same ratio with saturating Ca 2+ concentrations) and P (the ratio of the 380-nm fluorescence under minimum and maximum [Ca 2+ ] conditions, with K d being the dissociation constant of Ca 2+ and fura-2). The conversion variables Rmin, Rmax and K d p of equation (1) showed a more or less linear temperature dependence (Fig. 1) . The regression variables and the ratio of the fluorescent signals from single cells were used for estimation of [Ca 2+ ] ; in myotubes at various temperatures.
To record cytoplasmic Ca 2+ concentrations in several myotubes of the same culture, the positions of 10 cells were stored and revisited using a computer-controlled microscope stage (Zeiss). The fluorescence emission intensities were recorded in rapid succession from the 10 cells, the recording time being 1 s per cell, and the procedure was repeated in 30-s intervals (loops, see Pressmar and colleagues 26 ). Total recording time was 24 min. Ryanodine was normally applied after 3 min (i.e. after loop 6). In control experiments, no relevant artefacts were noted when water alone was applied.
Solutions and experimental conditions
The standard external solution used for recording Ca Ryanodine (Calbiochem, Bad Soden, Germany), highly purified and dissolved in water, was applied by adding the appropriate volume of the stock solution to the petri dish. Immediately after addition of the drug, the solution was stirred by gently pulling up and down the administering pipette. The final concentrations of ryanodine in the total volume of 18 ml in the dish were 0.5, 2 and 20 |imol litre" 1 . To adjust the desired temperature during an experiment, we used a homemade heatable copper insert for the microscope stage. The insert, carrying the culture dish, was insulated against the microscope stage by a layer of Teflon. Peltier elements, attached to the copper plate, heated or cooled the dish to the desired temperature in the range 2 0^1 °C with an accuracy of ±0.2°C. The temperature of the dish was recorded continuously and fed into the power control of the Peltier elements.
Statistical analysis
All data are given as mean (SD). TO test for significant differences between the responses of MHN and MHS cells, the Wilcoxon rank test for paired samples was used as pairs of MHS and control cultures were tested on the same day.
Equation (1) , and the increase was marked and remained more or less stable during the recording time when temperature was increased to 37°C (Fig. 2) . A similar response was observed at 41°C. De-regulation of [Ca 2+ ]j (i.e. a rapid and irreversible increase in response to ryanodine in the micromolar range) was not observed during the whole series of experiments. All myotubes were morphologically intact after the recordings.
Next we investigated the concentration dependence of the ryanodine effect at 37°C, mainly to characterize the threshold concentration. Figure 3A shows typical responses of control myotubes to ryanodine applied at different concentrations. The lowest concentration showing an effect was 0.5 |imol litre" . At the two highest concentrations, the responses of MHS and control myotubes were not remarkably different, but at 0.5 |Umol litre" 1 , the responses of the MHS cultures were faster (Fig. 4A) and/or reached higher levels than controls (Fig. 4B) . TO illustrate these differences in the kinetics of the ryanodine effect, we plotted the times required for reaching half-maximum response. At ryanodine 20 and 2 fimol litre" 1 , MHS and control cells were not different but at 0.5 |imol litre" 1 , the rate of rise of [Ca 2+ ]; in MHS myotubes was twice that of controls (Fig. 5A) .
A similar difference between MHS and controls was observed when the areas under the response curves obtained with ryanodine 0.5 jimol litre" 1 were plotted. For MHS myotubes these integrated [Ca 2+ ] ; values were, on average, more than twice those of controls (Fig. 5B) and this difference was even more prominent when data of tested pairs of MHS and control myotubes were compared individually. In seven of eight tests, the MHS/control ratios were: 1.9, 2.1, 3.3, 3.8, 4.3, 6.6 and 6.8. In only one experiment (represented by one of the open squares in Fig. 5 ), was the ratio reversed (0.7).
Discussion
Tissue cultures have been extremely useful for investigation of neuromuscular disorders. The major problems encoun- (SD) ). The data originate from experiments, as shown in A. The area included by the response curves was calculated for the various ryanodine concentrations. All recordings were made at 37°C using control myotubes. tered with cultured muscle are: (i) in comparison with adult muscle, maturation is incomplete and (ii) there are embryonic isoforms for various muscle proteins. Expression 27 28 and upregulation 29 of RYR1 has been demonstrated in cells at the myotube stage. In addition to the RYR1 gene, myotubes express RYR3 to a smaller extent, 30 but the formation of the triad system and the functional existence of depolarization-induced Ca 2+ release indicate that the RYR1 function is predominant. 31 Therefore, with respect to the expression of an MHS phenotype in culture, it was tempting to study muscle cell cultures from patients with mutations in the RYR1 gene.
Our finding that myotubes carrying the Gly2435Arg mutation in RYR1 have an increased sensitivity to ryanodine is compatible with another result obtained with the same mutant RYR1 receptor. When studied in SR vesicle preparations, the receptor showed enhanced sensitivity to activating calcium concentrations and, among other altered pharmacological properties, increased affinity to ryanodine. 8 Thus the faster kinetics of the [Ca 2+ ]j increase in the myotubes prepared from our probands may be explained by two mechanisms: (i) the higher affinity of the mutant receptors for ryanodine and (ii) an increase in calcium-induced calcium release as a consequence of local [Ca 2+ ] changes in the microenvironment of the receptors.
In Figure 5 , some overlap of the responses of MHS and control myotubes is evident. However, comparison of the responses of pairs of cultures tested on the same day clearly showed that under the most discriminating conditions (ryanodine 0.5 |0,mol litre" 1 and 37°C) MHS myotubes responded considerably stronger than controls. Probably factors other than genotype (e.g. cell density or stage of maturation of the culture) have a modulating influence on the response to ryanodine. This would explain why in some tests responses of either cell type (MHS or control) was stronger than in others. In our view, high standardization and maturation of cultures is recommended, and a control culture should be tested in parallel with each MHS case.
Significantly different results with MHS and control myotubes were obtained only when ryanodine was applied at the threshold concentration of 0.5 jxmol litre" 1 , and not with 2 or 20 fimol litre" 1 . This is similar to the IVCT in which the best distinction between MHS and control muscle bundles is achieved when caffeine and halothane are used at low concentrations. Interestingly, the concentration required for a significant increase in [Ca 2+ ]i in myotubes is close to the concentration used for the ryanodine contracture test (myotubes 0.5 |j.mol litre" 1 ; muscle bundles 1 |imol litre" 1 ). 16 In an earlier study, a concentration of ryanodine of at least 20 (imol litre" 1 was necessary to elicit an increase in [Ca 2+ ]; in myotubes. 22 The discrepancy in our data is explained by the fact that the earlier data were obtained at room temperature. We now know that the effect of ryanodine is temperature dependent (Fig. 2) .
Other possible explanations for our results would be that: (i) in the myotubes of MH patients, expression of the RYR1 gene is generally increased or (ii) RYR3 gene expression is increased. We consider these two possibilities unlikely because over-expression of the normal RYR1 in control myotubes alone does not confer the MHS phenotype to control myotubes. 21 Further, RYR3 is present only at low levels in myotubes and its expression is regulated by neurotrophic factors and electrical stimulation, factors which have little influence or should at least be constant in our culture system. Thus RYR3 probably contributes little to the observed ryanodine effects. In summary, the best explanation for the observed data is that in muscle cultured from patients, the threshold for activation of the mutant RYRs is lowered.
It is still not clear if muscle fibres from MHS probands have a higher resting cytoplasmic Ca 2+ concentration than controls. In some studies with porcine MH, it was claimed that resting cytoplasmic Ca 2+ concentrations were not increased 32 whereas in others a four-fold increase was reported. 33 A similar increase in resting [Ca 2+ ]j was reported for MHS individuals. 34 Our results with myotubes do not support increased resting concentrations but possibly other mutations lead to different results. For the RYR1 mutation, Argl63Cys, the calcium resting concentration of cultured myotubes was similar to controls. 21 Pigs homozygous for the Arg615Cys mutation have a tendency to develop muscle hypertrophy without exposure to any trigger substance. An increase in Ca 2+ release at rest or during normal muscle activity could be the reason for increased muscle growth.
Even at higher concentrations of ryanodine (20 or 50 |Limol litre" 1 ) we did not observe de-regulation of [Ca 2+ ]j (i.e. an uncontrolled increase in cytoplasmic Ca 2+ into the micromolar range). Such a de-regulation is assumed to occur during an MH crisis. Presumably, expression of Ca 2+ control proteins, including the SR Ca 2+ pumps, is balanced in cultured muscle in such a way that increased Ca 2+ release from RYRs cannot produce an 'MH crisis' in culture.
We conclude that muscle cultures are a promising tool for the study of MHS muscle. It seems possible to recognize the MHS phenotype in myotubes at the cellular level and to investigate if different RYR mutations lead to different responses. Thus it may be feasible to develop an MHS test based on muscle cultures.
